Ionis Pharma (IONS) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Join SI Premium – FREE
Ionis Pharma (NASDAQ: IONS) reported Q3 EPS of $0.06, $0.02 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $110.9 million versus the consensus estimate of $113.09 million.
For earnings history and earnings-related data on Ionis Pharma (IONS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Can broadening earnings growth sustain the equity upcycle? JPM weighs in
- Chilean Cobalt expands NeoRe rare earth project area to 67,400 hectares
- Artisan Partners Asset Management (APAM) PT Lowered at TD Cowen After 'Another Attrition-Driven Miss'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
